日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-World Effectiveness and Satisfaction with Risankizumab for the Treatment of Psoriatic Arthritis in Biologic-Naïve Patients: A Population Survey in the United States and Europe

利沙珠单抗治疗生物制剂初治银屑病关节炎患者的真实世界疗效和满意度：美国和欧洲人群调查

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00801-6
Walsh, Jessica A; Saffore, Christopher D; Ye, Xiaolan; Patel, Manish; Biljan, Ana; Vora, Jamie; Truman, Isabel; Edwards, Molly; Milligan, Gary; Ostor, Andrew
关节炎
银屑病
发表日期：2025
文献求助 收藏

Correction: Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis

更正：先进疗法治疗活动性强直性脊柱炎的临床和经济效益

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00626-1
Walsh, Jessica A; Saffore, Christopher D; Collins, Eric B; Ostor, Andrew
强直性脊柱炎
免疫/内分泌
发表日期：2024
文献求助 收藏

Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis

先进疗法治疗活动性强直性脊柱炎的临床和经济效益

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00586-6
Walsh, Jessica A; Saffore, Christopher D; Collins, Eric B; Ostor, Andrew
强直性脊柱炎
免疫/内分泌
发表日期：2023
文献求助 收藏

Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension

乌帕替尼治疗对非甾体抗炎药治疗反应不足的活动性强直性脊柱炎患者的安全性和有效性：一项双盲、安慰剂对照研究和开放标签扩展研究的一年结果

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.41911
Deodhar, Atul; van der Heijde, Désirée; Sieper, Joachim; Van den Bosch, Filip; Maksymowych, Walter P; Kim, Tae-Hwan; Kishimoto, Mitsumasa; Ostor, Andrew; Combe, Bernard; Sui, Yunxia; Chu, Alvina D; Song, In-Ho
强直性脊柱炎
免疫/内分泌
发表日期：2022
文献求助 收藏

Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials

乌帕替尼对活动性银屑病关节炎或强直性脊柱炎患者疼痛缓解的影响：三项随机临床试验的事后分析

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2021-002049
McInnes, Iain B; Ostor, Andrew J K; Mease, Philip J; Tillett, William; Baraliakos, Xenofon; de Vlam, Kurt; Bessette, Louis; Lippe, Ralph; Maniccia, Anna; Feng, Dai; Gao, Tianming; Zueger, Patrick; Saffore, Christopher; Kato, Koji; Song, In-Ho; Deodhar, Atul
强直性脊柱炎
关节炎
银屑病
免疫/内分泌
发表日期：2022
文献求助 收藏

Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2

利沙珠单抗治疗银屑病关节炎患者的患者报告结局得到改善：KEEPsAKE 2 3期试验分析

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2022-002286
Ostor, Andrew J K; Soliman, Ahmed M; Papp, Kim A; Padilla, Byron; Wang, Zailong; Eldred, Ann; de Vlam, Kurt; Kivitz, Alan
关节炎
银屑病
发表日期：2022
文献求助 收藏

Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review

类风湿性关节炎患者缓解的价值：一项针对性综述

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-021-01946-w
Ostor, Andrew J; Sawant, Ruta; Qi, Cynthia Z; Wu, Aozhou; Nagy, Orsolya; Betts, Keith A
关节炎
发表日期：2022
文献求助 收藏

Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response

在类风湿性关节炎患者中，使用upadacitinib或adalimumab联合甲氨蝶呤治疗48周的安全性和有效性，并对疗效不佳的患者更换其他治疗方案。

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2019-215764
Fleischmann, Roy M; Genovese, Mark C; Enejosa, Jeffrey V; Mysler, Eduardo; Bessette, Louis; Peterfy, Charles; Durez, Patrick; Ostor, Andrew; Li, Yihan; Song, In-Ho
关节炎
发表日期：2019
文献求助 收藏

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

参与阿达木单抗（修美乐）患者支持计划对类风湿性关节炎治疗过程的影响：PASSION 研究的结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-017-0061-7
Van den Bosch, Filip; Ostor, Andrew J K; Wassenberg, Siegfried; Chen, Naijun; Wang, Chen; Garg, Vishvas; Kalabic, Jasmina
关节炎
发表日期：2017
文献求助 收藏

Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

更正：参与阿达木单抗（修美乐）患者支持计划对类风湿性关节炎治疗过程的影响：PASSION 研究的结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-017-0065-3
Van den Bosch, Filip; Ostor, Andrew J K; Wassenberg, Siegfried; Chen, Naijun; Wang, Chen; Garg, Vishvas; Kalabic, Jasmina
关节炎
发表日期：2017
文献求助 收藏